InsiderTrades

Form 4 for LQDA Liquidia Corp

Accepted 2025-07-23 00:00:00 ET · period of report 2025-07-21 · accession 0001104659-25-070027 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2025-07-23 2025-07-21 LQDA Saggar Rajeev Chief Medical Off S - Sale $14.54 -2,526 268.9K -0.9% -$36.7K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-07-21 S D 2,526 $14.54 268,887 D — — (F2) These shares were sold to cover taxes associated with the settlement of restricted stock units ("RSUs") that were initially granted to the Reporting Person on July 18, 2022. (F3) Includes (i) 31,249 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 35,307 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4, and (iv) 6,291 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.